Péter Reményi
- Hematology top 10%
- Public Health, Environmental and Occupational Health
- Oncology
- Molecular Biology
- Infectious Diseases
- Co-authors
- Mohamad MohtyArnon NaglerMyriam LabopinHélène Labussière‐WalletGèrard SociéJakob PasswegLászló GopcsaMahmoud Aljurf
- Topics
- Hematopoietic Stem Cell Transplantation (19 papers)Acute Myeloid Leukemia Research (13 papers)Acute Lymphoblastic Leukemia research (13 papers)
- Journals
- BloodCancerClinical Cancer Research
In The Last Decade
Péter Reményi
28 papers receiving 209 citations
Peers
Comparison fields: 5 of 48
- Hematology 144
- Public Health, Environmental and Occupational Health 76
- Oncology 44
- Molecular Biology 34
- Infectious Diseases 31
Countries citing papers authored by Péter Reményi
This map shows the geographic impact of Péter Reményi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Reményi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Reményi more than expected).
Fields of papers citing papers by Péter Reményi
This network shows the impact of papers produced by Péter Reményi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Reményi. The network helps show where Péter Reményi may publish in the future.
Co-authorship network of co-authors of Péter Reményi
This figure shows the co-authorship network connecting the top 25 collaborators of Péter Reményi. A scholar is included among the top collaborators of Péter Reményi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Reményi. Péter Reményi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | Citokinellenes terápia az új típusú koronavírus okozta megbetegedés (COVID–19) kezelésében – tocilizumab elsőként való alkalmazása egy hazai infektológiai osztályon (A COVID–19-pandémia orvosszakmai kérdései) | 6 |
| 13 | 6 | |
| 14 | 22 | |
| 15 | 0 | |
| 16 | 1 | |
| 17 | 11 | |
| 18 | 12 | |
| 19 | 1 | |
| 20 | 5 |
About Péter Reményi
Péter Reményi is a scholar working on Hematology, Transplantation and Public Health, Environmental and Occupational Health, having authored 36 papers that have together received 217 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (13 papers). The work is most often cited by research in Hematology (144 citations), Transplantation (17 citations) and Public Health, Environmental and Occupational Health (76 citations). Péter Reményi has collaborated with scholars based in Hungary, France and Italy. Frequent co-authors include Mohamad Mohty, Arnon Nagler, Myriam Labopin, Hélène Labussière‐Wallet, Gèrard Socié, Jakob Passweg, László Gopcsa, Mahmoud Aljurf, Sebastian Giebel and Ibrahim Yakoub‐Agha. Their work appears in journals such as Blood, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.